Keefe, Bruyette & Woods Cuts Ryan Specialty (NYSE:RYAN) Price Target to $49.00

Ryan Specialty (NYSE:RYAN) had its price target lowered by analysts at Keefe, Bruyette & Woods from $55.00 to $49.00 in a research note issued on Tuesday,Benzinga reports. The brokerage presently has an “outperform” rating on the stock. Keefe, Bruyette & Woods’ target price points to a potential upside of 44.24% from the company’s previous close.

RYAN has been the topic of several other reports. Royal Bank Of Canada started coverage on Ryan Specialty in a report on Tuesday, March 17th. They set an “outperform” rating and a $45.00 price objective on the stock. Zacks Research cut Ryan Specialty from a “hold” rating to a “strong sell” rating in a report on Tuesday, February 24th. Mizuho decreased their price objective on Ryan Specialty from $53.00 to $44.00 and set a “neutral” rating on the stock in a report on Friday, February 27th. Citigroup decreased their price objective on Ryan Specialty from $60.00 to $55.00 and set a “buy” rating on the stock in a report on Monday, March 23rd. Finally, Weiss Ratings cut Ryan Specialty from a “hold (c-)” rating to a “sell (d+)” rating in a report on Thursday, February 5th. One research analyst has rated the stock with a Strong Buy rating, nine have given a Buy rating, five have given a Hold rating and three have assigned a Sell rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus target price of $53.81.

Ryan Specialty Price Performance

NYSE RYAN traded down $0.19 during trading hours on Tuesday, reaching $33.97. The company’s stock had a trading volume of 879,911 shares, compared to its average volume of 2,077,518. The firm’s 50-day moving average price is $39.24 and its 200-day moving average price is $48.87. The company has a quick ratio of 0.98, a current ratio of 0.98 and a debt-to-equity ratio of 2.62. Ryan Specialty has a 1 year low of $31.50 and a 1 year high of $75.26. The company has a market capitalization of $8.97 billion, a price-to-earnings ratio of 81.02, a PEG ratio of 0.88 and a beta of 0.71.

Ryan Specialty (NYSE:RYAN) last posted its quarterly earnings results on Thursday, February 12th. The company reported $0.45 EPS for the quarter, missing analysts’ consensus estimates of $0.50 by ($0.05). Ryan Specialty had a return on equity of 46.41% and a net margin of 7.02%.The business had revenue of $751.21 million during the quarter, compared to analysts’ expectations of $777.43 million. During the same period in the prior year, the firm posted $0.45 earnings per share. The firm’s revenue for the quarter was up 13.2% on a year-over-year basis. On average, equities research analysts predict that Ryan Specialty will post 2.29 EPS for the current fiscal year.

Insider Buying and Selling at Ryan Specialty

In related news, Director Patrick G. Ryan, Jr. bought 25,500 shares of the business’s stock in a transaction dated Monday, February 23rd. The shares were purchased at an average price of $39.96 per share, with a total value of $1,018,980.00. Following the transaction, the director owned 428,295 shares in the company, valued at $17,114,668.20. This trade represents a 6.33% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Corporate insiders own 52.21% of the company’s stock.

Hedge Funds Weigh In On Ryan Specialty

Several large investors have recently modified their holdings of the stock. Fund Advisors of America Inc FL bought a new position in shares of Ryan Specialty during the 4th quarter valued at approximately $277,000. Corient Private Wealth LLC increased its position in shares of Ryan Specialty by 5.0% during the 4th quarter. Corient Private Wealth LLC now owns 17,807 shares of the company’s stock valued at $919,000 after purchasing an additional 840 shares during the last quarter. EJMK Ventures LLC bought a new position in shares of Ryan Specialty during the 4th quarter valued at approximately $1,137,000. Caitong International Asset Management Co. Ltd increased its position in shares of Ryan Specialty by 491.5% during the 4th quarter. Caitong International Asset Management Co. Ltd now owns 1,532 shares of the company’s stock valued at $79,000 after purchasing an additional 1,273 shares during the last quarter. Finally, Pacer Advisors Inc. increased its position in shares of Ryan Specialty by 21.3% during the 4th quarter. Pacer Advisors Inc. now owns 17,988 shares of the company’s stock valued at $929,000 after purchasing an additional 3,155 shares during the last quarter. Institutional investors own 84.82% of the company’s stock.

About Ryan Specialty

Ryan Specialty Group, Inc (NYSE: RYAN) is a global specialty insurance and reinsurance platform that partners with a network of insurers and reinsurers to deliver tailored risk solutions. The company focuses on complex and large-scale risks across multiple industry sectors, leveraging its underwriting expertise to structure coverage programs that meet clients’ unique needs.

Ryan Specialty’s core offerings span a diverse range of specialty lines, including casualty, property, professional liability, marine and energy, program administration, and sports and entertainment.